Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cohen C. J., Goldberg J. D., Holland J. F., Bruckner H. W., Deppe G., Gusberg S. B., Wallach R. C., Kabakow B., Rodin J. Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation). Am J Obstet Gynecol. 1983 Apr 15;145(8):955–967. doi: 10.1016/0002-9378(83)90849-9. [DOI] [PubMed] [Google Scholar]
- Hubbard S. M., Barkes P., Young R. C. Adriamycin therapy for advanced ovarian carcinoma recurrent after chemotherapy. Cancer Treat Rep. 1978 Sep;62(9):1375–1377. [PubMed] [Google Scholar]
- Omura G. A., Bundy B. N., Berek J. S., Curry S., Delgado G., Mortel R. Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol. 1989 Apr;7(4):457–465. doi: 10.1200/JCO.1989.7.4.457. [DOI] [PubMed] [Google Scholar]
- Tomirotti M., Perrone S., Giè P., Canaletti R., Carpi A., Biasoli R., Lombardi F., Giovanninetti A., Mensi F., Villa S. Cisplatin (P) versus cyclophosphamide, adriamycin and cisplatin (CAP) for stage III-IV epithelial ovarian carcinoma: a prospective randomized trial. Tumori. 1988 Oct 31;74(5):573–577. doi: 10.1177/030089168807400514. [DOI] [PubMed] [Google Scholar]
- Whitehouse J. M. Best documented practice. BMJ. 1989 Jun 10;298(6687):1536–1537. doi: 10.1136/bmj.298.6687.1536. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wiltshaw E., Evans B., Rustin G., Gilbey E., Baker J., Barker G. A prospective randomized trial comparing high-dose cisplatin with low-dose cisplatin and chlorambucil in advanced ovarian carcinoma. J Clin Oncol. 1986 May;4(5):722–729. doi: 10.1200/JCO.1986.4.5.722. [DOI] [PubMed] [Google Scholar]